Pseudo-pseudomyxoma peritonei from peritoneal sarcomatosis

作者: Shuja Ahmed , Ling Guo , Shadi A. Qasem , Edward A. Levine

DOI: 10.5430/CRCP.V2N4P14

关键词: Myxoid liposarcomaInguinal herniaSurgerySarcomatosisMedicinePseudomyxoma peritoneiSarcomaRare diseaseHyperthermic intraperitoneal chemotherapyAbdominal pain

摘要: Background: Pseudomyxoma peritonei (PMP) is a rare clinical entity of mucinous ascites, most commonly associated with appendiceal neoplasms. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remains the current standard care for PMP. Peritoneal sarcomatosis (PS) an exceptionally disease poor prognosis. PMP PS has not been previously described. The role cytoreductive or without well-defined. manifesting like Case presentation: A 74-year-old patient several weeks history vague abdominal pain increased girth was referred to our facility after incidental finding during laparoscopic inguinal hernia repair. After complete work-up, he advised undergo CRS/HIPEC. Intra-operatively, noted have extensive ascites underwent aggressive CRS HIPEC Result: Final pathology revealed myxoid liposarcoma mucin dissemination, which confirmed cytogenetic analysis. Conclusion: We describe case pseudomyxoma originating from intra-abdominal sarcoma. propose term “pseudo-pseudomyxoma peritonei” appropriately this unusual event.

参考文章(13)
Pierre Jacquet, Paul H. Sugarbaker, Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer treatment and research. ,vol. 82, pp. 359- 374 ,(1996) , 10.1007/978-1-4613-1247-5_23
Reese W. Randle, Katrina R. Swett, Perry Shen, John H. Stewart, Edward A. Levine, Konstantinos I. Votanopoulos, Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis. American Surgeon. ,vol. 79, pp. 620- 624 ,(2013) , 10.1177/000313481307900624
Rhonda L Harmon, Paul H Sugarbaker, Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer International Seminars in Surgical Oncology. ,vol. 2, pp. 3- 3 ,(2005) , 10.1186/1477-7800-2-3
Chunyanca Li, Rani Kanthan, SC Kanthan, Pseudomyxoma peritonei – a revisit: report of 2 cases and literature review World Journal of Surgical Oncology. ,vol. 4, pp. 60- 60 ,(2006) , 10.1186/1477-7819-4-60
Natsuo Yasui, Takahiro Kubo, Kenji Endo, Yoshito Matsui, Tadashi Hasegawa, Kayo Suzuki, Tomoatsu Kimura, Osamu Ohtani, Myxoid Liposarcoma with EWS–CHOP Type 1 Fusion Gene Anticancer Research. ,vol. 30, pp. 4679- 4683 ,(2010)
Robert M. Smeenk, Vic J. Verwaal, Ninja Antonini, Frans A. N. Zoetmulder, Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Annals of Surgery. ,vol. 245, pp. 104- 109 ,(2007) , 10.1097/01.SLA.0000231705.40081.1A
Taku Naiki, Shuzo Hamamoto, Noriyasu Kawai, Aya Naiki-Ito, Yoshiyuki Kojima, Takahiro Yasui, Keiichi Tozawa, Kenjiro Kohri, Giant Retroperitoneal Mucinous Tumor Supportively Diagnosed as a Dedifferentiated Liposarcoma by Fluorescence In Situ Hybridization of MDM2 Gene. International Scholarly Research Notices. ,vol. 2011, pp. 261735- 261735 ,(2011) , 10.5402/2011/261735
Haroon Asif Choudry, Arun Mavanur, Mark E. O’Malley, Herbert J. Zeh, Z. Sheng Guo, David L. Bartlett, Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei Annals of Surgical Oncology. ,vol. 19, pp. 1402- 1409 ,(2012) , 10.1245/S10434-012-2242-5
C.Hiram Weaver, Mucocele of appendix with pseudomucinous degeneration American Journal of Surgery. ,vol. 36, pp. 523- 526 ,(1937) , 10.1016/S0002-9610(37)90763-3
Graadt van Roggen, Hogendoorn, M Fletcher, Myxoid tumours of soft tissue Histopathology. ,vol. 35, pp. 291- 312 ,(1999) , 10.1046/J.1365-2559.1999.00835.X